Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Prognostic Significance of Adenocarcinoma in situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients with Stage I Disease. American Joumal of Surgical Pathology. 2013 (in press)
Kachala S, Bograd A, Villena-Vargas J, Suzuki K, Servais EL, Kadota K, Chou J, Sima CS, Vertes E, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Mesothelin overexpression is a marker of tumor aggressiveness and its associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res. 2013 (in press)
Villena-Vargas J, Adusumilli PS. Mesothelin-targeted immunotherapies for malignant pleural mesothelioma. Annals of Cardiothoracic Surgery. 2012 Nov;1(4): 466-471.
Colovos C, Villena-Vargas J, Adusumilli PS. Safety and stability ofretrovirally transduced chimeric antigen receptor T cells. Immunotherapy. 2012 Sep;4(9):899-902. PMID: 23046233.
Villena-Vargas J, Cherkassky L, Colovos C, Servais E, Rodriguez L, Rusch VW, Sadelain M, Adusumilli PS. Critical role of CD28 costimulation in tumor-targeted T -cell therapy clinical trial for pleural malignancies. 15th World Conference on Lung Cancer, 2013 October 27-30; Sydney, Australia. (Oral Presentation)
Villena-Vargas J, Rodriguez L, Moroz M, Cherkassky L, Rusch VW, Sadelain M, Ponomarev V, Adusumilli PS. T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies. 15th World Conference on Lung Cancer, 2013 October 27-30; Sydney, Australia. (Oral Presentation)
Xu C, Villena-Vargas J, Sadelain M, Adusumilli PS. Induction of T-regs in chimeric antigen receptor (CAR)-transduced T cells: Role of costimulation and tumor-secreted TFG-p. 36th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 1, 2013; New York, NY. (Poster)